Clinical Trials Browser

ibrutinib × Genitourinary × 1 year × Clear all

NCT02899078 2025-05-18

Ibrutinib and Nivolumab in Treating Patients With Previously-Treated Metastatic Kidney Cancer

Phase 1/2 Completed

31 enrolled 11 charts

Carcinoma, Renal Cell